Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the closing of its ...

Atlanta, GA, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IDAI), a global provider of AI-powered technologies, today announced that it has entered into a securities purchase agreement with a single ...

Shares of Amesite were down 15% to $3.45 in after-hours trading Monday following an announcement of a public offering. In a prospectus supplement, the company reiterated that there is substantial ...

Aegis Capital Corp. is acting as the sole book-running manager for the Offering on a firm commitment basis. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, ...

AEON Biopharma (AEON) announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be ...

Expion360 Inc. (Nasdaq: XPON) (the “Company”), an industry leader in lithium-ion battery power storage solutions, today announced the closing of its previously ...

Veritone, Inc. (NASDAQ: VERI) disclosed on January 2, 2025, that it has entered into a securities purchase agreement with Esousa Group Holdings, LLC, a New York-based family office, for a registered ...

Veritone shares are trading lower by 3% during Thursday's session. The company announced a direct offering agreement to sell ...

Shares of Expion360 surged after the company reported strong preliminary sequential revenue growth and said it started distributing its e360 Home Energy Storage Solutions, then retreated after the ...

Expion360 Inc. (Nasdaq: XPON) (the “Company”), an industry leader in lithium-ion battery power storage solutions, today announced that it has entered into ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $20.3 million, before deducting offering expenses payable by the Company. The Company intends to use the ...

The company entered into a definitive agreement providing for the purchase and sale of ~8.02M shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $2.53 per share (or ...